Clinical Trial Update: A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata [Phase 3]

View source ↗

Summary

Pfizer is conducting a Phase 3 trial of ritlecitinib in children aged 6 to 12 with severe alopecia areata, and the study is currently recruiting. This is a stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Ritlecitinib (ritlecitinib)

Snippet

Sponsor: Pfizer | Conditions: Severe Alopecia Areata | Phase 3 | Status: RECRUITING